| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
|
Nat Genet
|
2010
|
17.89
|
|
2
|
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.
|
Nat Genet
|
2010
|
6.66
|
|
3
|
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.
|
Proc Natl Acad Sci U S A
|
2007
|
4.62
|
|
4
|
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.
|
Nat Genet
|
2012
|
4.37
|
|
5
|
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.
|
Diabetes
|
2010
|
4.07
|
|
6
|
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|
PLoS Genet
|
2012
|
3.21
|
|
7
|
Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons.
|
Nat Neurosci
|
2008
|
3.11
|
|
8
|
The role of incretins in glucose homeostasis and diabetes treatment.
|
Pharmacol Rev
|
2008
|
2.73
|
|
9
|
Mechanisms of action of glucagon-like peptide 1 in the pancreas.
|
Pharmacol Ther
|
2006
|
2.71
|
|
10
|
Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats.
|
Hippocampus
|
2008
|
2.44
|
|
11
|
Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study.
|
Clin Endocrinol (Oxf)
|
2010
|
2.24
|
|
12
|
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
|
Am J Physiol Endocrinol Metab
|
2005
|
2.18
|
|
13
|
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
|
Proc Natl Acad Sci U S A
|
2009
|
2.15
|
|
14
|
A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.
|
PLoS Genet
|
2009
|
2.09
|
|
15
|
Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction.
|
Proc Natl Acad Sci U S A
|
2008
|
1.97
|
|
16
|
Modulation of taste sensitivity by GLP-1 signaling.
|
J Neurochem
|
2008
|
1.89
|
|
17
|
SRT1720 improves survival and healthspan of obese mice.
|
Sci Rep
|
2011
|
1.81
|
|
18
|
Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals.
|
Atherosclerosis
|
2009
|
1.78
|
|
19
|
miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression.
|
Mol Cell Biol
|
2010
|
1.75
|
|
20
|
A genome-wide association search for type 2 diabetes genes in African Americans.
|
PLoS One
|
2012
|
1.72
|
|
21
|
The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women.
|
Br J Nutr
|
2013
|
1.56
|
|
22
|
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
|
J Pharmacol Exp Ther
|
2002
|
1.51
|
|
23
|
Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
|
J Neurosci Res
|
2003
|
1.45
|
|
24
|
Pharmacological agents that directly modulate insulin secretion.
|
Pharmacol Rev
|
2003
|
1.45
|
|
25
|
Incretin-based therapies in type 2 diabetes mellitus.
|
J Clin Endocrinol Metab
|
2008
|
1.45
|
|
26
|
Bitter taste receptors influence glucose homeostasis.
|
PLoS One
|
2008
|
1.44
|
|
27
|
A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
|
J Pharmacol Exp Ther
|
2002
|
1.43
|
|
28
|
Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.
|
Diabetes
|
2008
|
1.42
|
|
29
|
Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.
|
Diabetes Care
|
2003
|
1.37
|
|
30
|
Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging.
|
PLoS One
|
2010
|
1.32
|
|
31
|
Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells.
|
Diabetes
|
2011
|
1.26
|
|
32
|
RNA-binding protein HuD controls insulin translation.
|
Mol Cell
|
2012
|
1.25
|
|
33
|
Peptide YY is secreted after oral glucose administration in a gender-specific manner.
|
J Clin Endocrinol Metab
|
2005
|
1.25
|
|
34
|
Quadriceps strength, quadriceps power, and gait speed in older U.S. adults with diabetes mellitus: results from the National Health and Nutrition Examination Survey, 1999-2002.
|
J Am Geriatr Soc
|
2013
|
1.23
|
|
35
|
Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.
|
Am J Physiol Endocrinol Metab
|
2007
|
1.22
|
|
36
|
Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.
|
Diabetes
|
2009
|
1.20
|
|
37
|
Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.
|
Diabetes
|
2010
|
1.16
|
|
38
|
Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.
|
Cell Metab
|
2013
|
1.14
|
|
39
|
Perinatal exercise improves glucose homeostasis in adult offspring.
|
Am J Physiol Endocrinol Metab
|
2012
|
1.13
|
|
40
|
Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes.
|
Diabetes Care
|
2003
|
1.12
|
|
41
|
Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging.
|
J Clin Endocrinol Metab
|
2012
|
1.09
|
|
42
|
Diabetes and altered glucose metabolism with aging.
|
Endocrinol Metab Clin North Am
|
2013
|
1.09
|
|
43
|
Insulin and glucagon regulate pancreatic α-cell proliferation.
|
PLoS One
|
2011
|
1.08
|
|
44
|
Glucagon signaling modulates sweet taste responsiveness.
|
FASEB J
|
2010
|
1.08
|
|
45
|
Conserved and differential effects of dietary energy intake on the hippocampal transcriptomes of females and males.
|
PLoS One
|
2008
|
1.07
|
|
46
|
Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness.
|
Am J Hypertens
|
2010
|
1.05
|
|
47
|
Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.
|
Diabetes
|
2013
|
1.04
|
|
48
|
Glucose and insulin measurements from the oral glucose tolerance test and mortality prediction.
|
Diabetes Care
|
2008
|
1.03
|
|
49
|
Ghrelin is produced in taste cells and ghrelin receptor null mice show reduced taste responsivity to salty (NaCl) and sour (citric acid) tastants.
|
PLoS One
|
2010
|
1.01
|
|
50
|
The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity.
|
Regul Pept
|
2003
|
1.01
|
|
51
|
GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.
|
Obesity (Silver Spring)
|
2008
|
1.01
|
|
52
|
Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study.
|
Am J Physiol Endocrinol Metab
|
2006
|
1.00
|
|
53
|
Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.
|
Histol Histopathol
|
2008
|
0.99
|
|
54
|
Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation.
|
Sci Signal
|
2012
|
0.97
|
|
55
|
Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors.
|
J Cell Physiol
|
2002
|
0.97
|
|
56
|
Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
|
J Surg Res
|
2010
|
0.97
|
|
57
|
Hormones in the naso-oropharynx: endocrine modulation of taste and smell.
|
Trends Endocrinol Metab
|
2009
|
0.96
|
|
58
|
Exendin-4 pharmacodynamics: insights from the hyperglycemic clamp technique.
|
J Pharmacol Exp Ther
|
2004
|
0.96
|
|
59
|
Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides.
|
J Pharmacol Exp Ther
|
2010
|
0.96
|
|
60
|
Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia.
|
J Clin Endocrinol Metab
|
2013
|
0.94
|
|
61
|
Glucagon-like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons.
|
J Neurochem
|
2003
|
0.94
|
|
62
|
Glucose tolerance, glucose utilization and insulin secretion in ageing.
|
Novartis Found Symp
|
2002
|
0.94
|
|
63
|
Reduced energy intake: the secret to a long and healthy life?
|
IBS J Sci
|
2007
|
0.93
|
|
64
|
Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance.
|
Diabetes Care
|
2004
|
0.93
|
|
65
|
Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism.
|
J Clin Endocrinol Metab
|
2011
|
0.93
|
|
66
|
Notch signaling in pancreatic endocrine cell and diabetes.
|
Biochem Biophys Res Commun
|
2009
|
0.92
|
|
67
|
Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.
|
J Biol Chem
|
2012
|
0.91
|
|
68
|
Caloric restriction: impact upon pituitary function and reproduction.
|
Ageing Res Rev
|
2008
|
0.91
|
|
69
|
Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways.
|
Diabetologia
|
2014
|
0.89
|
|
70
|
Age-related changes in mouse taste bud morphology, hormone expression, and taste responsivity.
|
J Gerontol A Biol Sci Med Sci
|
2011
|
0.86
|
|
71
|
Vismodegib, an antagonist of hedgehog signaling, directly alters taste molecular signaling in taste buds.
|
Cancer Med
|
2014
|
0.85
|
|
72
|
The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
|
Crit Care Med
|
2014
|
0.85
|
|
73
|
Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.
|
Diabetes Care
|
2003
|
0.84
|
|
74
|
Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?
|
Hypertension
|
2009
|
0.84
|
|
75
|
In vivo biological activity of exendin (1-30).
|
Endocrine
|
2005
|
0.82
|
|
76
|
Roles of hormones in taste signaling.
|
Results Probl Cell Differ
|
2010
|
0.81
|
|
77
|
GIP contributes to islet trihormonal abnormalities in type 2 diabetes.
|
J Clin Endocrinol Metab
|
2014
|
0.81
|
|
78
|
Pancreas++: automated quantification of pancreatic islet cells in microscopy images.
|
Front Physiol
|
2013
|
0.80
|
|
79
|
Selective contribution of regional adiposity, skeletal muscle, and adipokines to glucose disposal in older adults.
|
J Am Geriatr Soc
|
2012
|
0.79
|
|
80
|
Identification of CB1/CB2 ligands from Zanthoxylum bungeanum.
|
J Nat Prod
|
2013
|
0.79
|
|
81
|
To be or not to be--obese.
|
Endocrinology
|
2011
|
0.79
|
|
82
|
Assessment of insulin sensitivity and secretion indices from oral glucose tolerance testing in subjects with fasting euglycemia but impaired 2-hour plasma glucose.
|
Metabolism
|
2003
|
0.79
|
|
83
|
Role and development of GLP-1 receptor agonists in the management of diabetes.
|
Diabetes Metab Syndr Obes
|
2009
|
0.78
|
|
84
|
Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetes.
|
PLoS One
|
2012
|
0.78
|
|
85
|
Contribution of nonesterified fatty acids to insulin resistance in the elderly with normal fasting but diabetic 2-hour postchallenge plasma glucose levels: the Baltimore Longitudinal Study of Aging.
|
Metabolism
|
2007
|
0.77
|
|
86
|
High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer.
|
J Androl
|
2010
|
0.76
|
|
87
|
Targeting Stem Cells in Chronic Myeloid Leukemia with a PPAR-γ Agonist.
|
N Engl J Med
|
2015
|
0.75
|